Tissue engineering has the potential to serve as an alternative to surgical tissue transfer for the management of soft tissue defects. The perceived advantages include reduced donor site morbidity and restoration of function and aesthetics to ideal. Degradable scaffolds are utilised in the early stages of cell growth and development with the advantage of eventual elimination to leave space for the engineered tissue and a reduced chance of rejection
